Larimef Tablet
By Larimef
Rx
6 Tablet in a Strip

Composition
Mefloquine(250mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
July, 2026

liver
When using Larimef Tablet, it is essential to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication, so consulting your doctor before starting treatment is crucial. It is also important to note that using Larimef Tablet is not advised for individuals with severe liver disease.

kidney
Limited data exists on using Larimef Tablet in kidney disease patients. Consult your doctor for guidance.

alcohol
Caution is advised when consuming alcohol with Larimef Tablet. Consult your doctor.

driving
Larimef Tablet may lead to side effects like dizziness, loss of balance, and mental issues, impacting driving ability.

pregnancy
Larimef Tablet may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Kindly consult your doctor.

breastfeeding
Larimef Tablet is considered safe for use during breastfeeding based on limited human data. The drug is not likely to pose a significant risk to the baby.
Habit Forming | No |
Chemical Class | 4-Quinolinemethanol derivative |
Therapeutic Class | ANTI MALARIALS |
Action Class | Antimalarial- others |
₹341
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024